BRAINTREE, Mass., Nov. 18, 2016 /PRNewswire/ -- Haemonetics®, a healthcare technology provider dedicated to delivering innovative products and solutions to healthcare organizations around the world, today announced it deployed its BloodTrack® Emerge® software at The Medical Center of Plano.
Joining several leading healthcare institutions in the United States, The Medical Center of Plano is the first to use this technology in Texas, and will deploy BloodTrack® within its Emergency Department (ED) to provide authorized caregivers with "just-in-time blood management" in the trauma room.
Treating 30-40 traumas per month, physicians at the hospital can begin the resuscitation process for critically injured patients by obtaining blood products directly from the BloodTrack® Emerge® system in the trauma room.
"Haemonetics is dedicated to helping hospitals improve their blood supply chain to enhance patient safety, advance the quality of medical care and lower costs," said Christopher Simon, CEO of Haemonetics. "We are delighted to provide just-in-time blood management for The Medical Center of Plano and proud to have them join some of the leading healthcare providers in the nation."
"Every second counts, and having immediate access to blood products can make a life-saving difference," said Matthew Carrick, MD, Medical Director of Trauma Services at The Medical Center of Plano. "As our market's leading trauma facility, we treat the most critically injured patients and BloodTrack® gives us peace of mind knowing our patients have the most advanced technology available to treat all trauma cases."
About BloodTrack® Software
BloodTrack® is a modular suite of software and hardware solutions that act as an extension of the hospital's Blood Bank Information System to electronically secure, verify and monitor each link in the blood supply chain from blood bank to bedside. Using BloodTrack® Solutions provides the necessary control, visibility and traceability to safely store and properly dispense blood products in clinical areas; such as surgery, ICU and emergency, providing secure, fully traceable point-of-care blood management. To learn more about BloodTrack, please visit http://bloodtrack.haemonetics.com
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, please visit http://www.haemonetics.com/
Gerry Gould, VP, Investor Relations
Sandra Jesse, EVP, Chief Legal Officer